AI-based online tutor developer Riiid raised a sizeable $175m round from SoftBank. Riiid is part of the broader edtech space, which has been given much attention by corporate investors in recent years.
Month: May 2021
Daily Deal Round Up: May 28, 2021
Lilly Asia Ventures took part in a $78m round for oncology therapy developer BH Med while gifting platform developer Snappy completed a $70m Hearst-backed series C.
Emerging Leaders Q&A – Arun Chetty & Tianlin Wang, Intel Capital
Q&A with Intel Capital managing directors Arun Chetty and Tianlin Wang
Sub-sector: care provision and on demand services
The gamification of life continues, just updated for the modern world it seems.
JD Logistics delivers $3.2bn initial public offering
JD.com has followed up the December flotation of its JD Health spinoff by listing its Tencent and China Life-backed logistics vehicle.
Full Truck Alliance formulates $1.5bn IPO filing
Vision Fund is the largest shareholder of freight services provider Full Truck Alliance, which is reportedly seeking a $20bn valuation when it floats.
QuintoAndar hikes to $300m series E
SoftBank Innovation Fund has chipped in for a round that valued the rental listings marketplace at $4bn, increasing its overall funding to $635m.
Acorns to grow with reverse takeover plans
The Comcast, PayPal and Rakuten-backed micro-investing service is merging with Nasdaq-listed Pioneer Merger Corp at a $2.2bn post-transaction valuation.
Tritium ties up $1.2bn reverse merger
The Gilbarco Veeder-Root, Varley Group and Cigna-backed electric vehicle charging technology developer will list through a $1.2bn reverse merger deal.
Day One begins $160m IPO
Access Industries and Takeda scored exits as the oncology therapy developer floated at the top of its range in an upsized offering.
PayPal pitches in $50m for diverse venture capital
A total of 11 early-stage venture capital funds run by members of the black and Latinx community have secured part of $50m of commitments from PayPal.
OpenAI ropes in Microsoft for $100m fund
Microsoft has contributed to the artificial intelligence technology developer’s OpenAI Startup Fund, two years after investing $1bn in the company.
Lyell Immunopharma lines up $150m IPO
The GlaxoSmithKline and Celgene-backed immunotherapy developer has revealed its intention to float on the Nasdaq Global Market.
Effector exercises reverse merger
The Pfizer, GlaxoSmithKline, Novartis, AbbVie and Astellas-backed oncology therapy developer is set to go public through a reverse takeover.